Chir 99021 and Impurities
Ref: 4Z-C-427002
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Thursday 5 Dec 2024
Ref: 4Z-C-427001
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Thursday 5 Dec 2024
Ref: 4Z-C-427004
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Wednesday 11 Dec 2024
Ref: 4Z-C-427005
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Wednesday 11 Dec 2024
CHIR-99021
CAS:252917-06-9
View and buy CHIR-99021 from TargetMol.CHIR-99021 is a GSK-3α/β inhibitor.Cited in 10 publications.
Formula:
C22H18Cl2N8
Purity:
97.94% - ≥95%
Color and Shape:
Solid
Molecular weight:
465.34
Ref: TM-T2310
2mg | 48.00 € | ||
5mg | 69.00 € | ||
10mg | 92.00 € | ||
25mg | 165.00 € | ||
50mg | 259.00 € | ||
100mg | 409.00 € | ||
200mg | 608.00 € | ||
500mg | 941.00 € | ||
1mL*10mM (DMSO) | 70.00 € |
Estimated delivery in United States, on Wednesday 11 Dec 2024
Ref: 4Z-C-427006
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Wednesday 11 Dec 2024
Ref: 4Z-C-427003
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Wednesday 11 Dec 2024
Laduviglusib trihydrochloride
CAS:1782235-14-6
Laduviglusib trihydrochloride, a GSK-3α/β inhibitor (IC50: 10/6.7 nM), activates Wnt/β-catenin signaling and induces autophagy.
Formula:
C22H20Cl5N8
Purity:
99.03%
Color and Shape:
Solid
Molecular weight:
573.71
Ref: TM-T22657
1mg | 42.00 € | ||
2mg | 56.00 € | ||
5mg | 92.00 € | ||
10mg | 134.00 € | ||
25mg | 263.00 € | ||
50mg | 498.00 € | ||
100mg | 667.00 € | ||
500mg | 1,392.00 € | ||
1mL*10mM (DMSO) | 106.00 € |
Estimated delivery in United States, on Wednesday 22 Jan 2025